Decoy Therapeutics is trading 5.07% up at $2.90 after rising from the September 9 close of $2.76.
- The company is scheduled to present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference on September 10.
- Available coverage does not confirm the event as the cause of the pre-market move, while broader markets are mixed and the specific catalyst remains uncertain.